These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 25986067)

  • 1. Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report.
    Solbach P; Potthoff A; Raatschen HJ; Soudah B; Lehmann U; Schneider A; Gebel MJ; Manns MP; Vogel A
    BMC Gastroenterol; 2015 May; 15():60. PubMed ID: 25986067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatocellular carcinoma associated with recreational anabolic steroid use.
    Gorayski P; Thompson CH; Subhash HS; Thomas AC
    Br J Sports Med; 2008 Jan; 42(1):74-5; discussion 75. PubMed ID: 18178686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature.
    Socas L; Zumbado M; Pérez-Luzardo O; Ramos A; Pérez C; Hernández JR; Boada LD
    Br J Sports Med; 2005 May; 39(5):e27. PubMed ID: 15849280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multiple hepatocellular adenomas and renal cell carcinoma associated with anabolic androgenic steroids].
    Morozova MM; Ivanova EI; Chardarov NK; Dolzhanskiy OV; Shatveryan GA; Kamalov YR
    Khirurgiia (Mosk); 2021; (10):105-109. PubMed ID: 34608788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatology: hepatocellular carcinoma in a young man secondary to androgenic anabolic steroid abuse.
    Kesler T; Sandhu RS; Krishnamoorthy S
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1852. PubMed ID: 25392920
    [No Abstract]   [Full Text] [Related]  

  • 6. Androgenic-anabolic steroid therapy and hepatocellular carcinoma.
    Henderson JT; Richmond J; Sumerling MD
    Lancet; 1973 Apr; 1(7809):934. PubMed ID: 4123858
    [No Abstract]   [Full Text] [Related]  

  • 7. [Cardiovascular alterations associated with doping].
    Thieme D; Büttner A
    Herz; 2015 May; 40(3):410-6. PubMed ID: 25828698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Liver pathology associated with anabolic androgenic steroids].
    Søe KL; Søe M; Gluud CN
    Ugeskr Laeger; 1994 Apr; 156(17):2585-8. PubMed ID: 8016966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatotoxicity associated with illicit use of anabolic androgenic steroids in doping.
    Solimini R; Rotolo MC; Mastrobattista L; Mortali C; Minutillo A; Pichini S; Pacifici R; Palmi I
    Eur Rev Med Pharmacol Sci; 2017 Mar; 21(1 Suppl):7-16. PubMed ID: 28379599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of androgenic-anabolic steroid therapy with development of hepatocellular carcinoma.
    Johnson FL; Lerner KG; Siegel M; Feagler JR; Majerus PW; Hartmann JR; Thomas ED
    Lancet; 1972 Dec; 2(7790):1273-6. PubMed ID: 4117807
    [No Abstract]   [Full Text] [Related]  

  • 11. Reversible hypogonadism and azoospermia as a result of anabolic-androgenic steroid use in a bodybuilder with personality disorder. A case report.
    Boyadjiev NP; Georgieva KN; Massaldjieva RI; Gueorguiev SI
    J Sports Med Phys Fitness; 2000 Sep; 40(3):271-4. PubMed ID: 11125771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Illicit use and abuse of anabolic-androgenic steroids among Brazilian bodybuilders.
    Santos AM; da Rocha MS; da Silva MF
    Subst Use Misuse; 2011; 46(6):742-8. PubMed ID: 21114402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative course and anabolic-androgenic steroid abuse -- a case report.
    Medras M; Tworowska U; Jozkow P; Dumanski A; Dubinski A
    Anaesthesia; 2005 Jan; 60(1):81-4. PubMed ID: 15601278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Giant hepatic adenoma associated with anabolic-androgenic steroid abuse: case report.
    Pais-Costa SR; Lima OA; Soares AF
    Arq Bras Cir Dig; 2012; 25(3):180-2. PubMed ID: 23411809
    [No Abstract]   [Full Text] [Related]  

  • 15. Impaired vasoreactivity in bodybuilders using androgenic anabolic steroids.
    Lane HA; Grace F; Smith JC; Morris K; Cockcroft J; Scanlon MF; Davies JS
    Eur J Clin Invest; 2006 Jul; 36(7):483-8. PubMed ID: 16796605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgenic/Anabolic steroid-induced toxic hepatitis.
    Stimac D; Milić S; Dintinjana RD; Kovac D; Ristić S
    J Clin Gastroenterol; 2002 Oct; 35(4):350-2. PubMed ID: 12352300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abuse of anabolic androgenic steroids and related substances in sport and exercise.
    Bahrke MS; Yesalis CE
    Curr Opin Pharmacol; 2004 Dec; 4(6):614-20. PubMed ID: 15525553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anabolic steroid abuse causing recurrent hepatic adenomas and hemorrhage.
    Martin NM; Abu Dayyeh BK; Chung RT
    World J Gastroenterol; 2008 Jul; 14(28):4573-5. PubMed ID: 18680242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A jaundiced bodybuilder Cholestatic hepatitis as side effect of injectable anabolic-androgenic steroids.
    Boks MN; Tiebosch AT; van der Waaij LA
    J Sports Sci; 2017 Nov; 35(22):2262-2264. PubMed ID: 27937337
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple hepatic adenomas after long-term therapy with testosterone enanthate. Review of the literature.
    Carrasco D; Prieto M; Pallardó L; Moll JL; Cruz JM; Muñoz C; Berenguer J
    J Hepatol; 1985; 1(6):573-8. PubMed ID: 2997324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.